Delivery Order SPE2DR25D1017-SPE2DR26F9DDN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,442.36 to AmerisourceBergen Drug Corp for the supply of Depakote DR 125 mg Sprinkle Capsules (100-count) on December 18, 2025, with an ultimate completion date of December 19, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a competitive award under the company's larger pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $3,092.44 to AmerisourceBergen Drug Corp for 100 units of Depakote DR 125 mg Sprinkle capsules, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Depakote DR 125 mg Sprinkle capsules (100-count packaging) with a ceiling value of $5,463.37. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 19, 2025, and performance to occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Depakote DR 125 mg Sprinkle capsules (100-count bottles). This firm fixed-price delivery order, valued at $14,147.88, was competitively awarded without set-aside designation and carries an ultimate completion date of September 23, 2025. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Depakote DR 125 mg Sprinkle capsules (100-count) with a ceiling value of $1,314.68. This is a firm fixed-price delivery order with an ultimate completion date of December 19, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Depakote DR 125 mg sprinkle capsules (100-count unit) valued at $1,458.55. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award utilized firm fixed pricing with no set-aside designation, reflecting...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Depakote DR 125 mg sprinkle capsules (100 count) with a ceiling value of $3,165.70. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is scheduled for ultimate completion on September 5, 2025, with performance taking place at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Depakote DR 125 mg sprinkle capsules (100 count) valued at $1,014.58, with performance in Conshohocken, Pennsylvania and completion by June 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order valued at $3,014.25 to AmerisourceBergen Drug Corp for Depakote DR 125 mg Sprinkle capsules (100 count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single shipment of this anticonvulsant and mood-stabilizing medication,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,003.25 to AmerisourceBergen Drug Corp for Depakote DR 125 mg Sprinkle capsules (100-count units). This firm fixed-price delivery order, issued on August 15, 2025, with a completion date of August 18, 2025, represents a non-set-aside award. The product will be performed at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9DDNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,515.48 to AmerisourceBergen Drug Corp for the supply of Depakote DR 125 mg Sprinkle capsules (100 count) on January 13, 2026, with an ultimate completion date of January 14, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and subsidiary of Cencora, Inc., serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support to military healthcare programs, enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. The Depakote delivery represents a routine pharmaceutical fulfillment supporting the Defense Health Agency and other federal healthcare systems requiring neurological treatments for conditions such as epilepsy and bipolar disorder.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 1/12/26 |